Respiratory syncytial virus
- Core value dossier for a treatment for respiratory syncytial virus
- Core value dossier update in respiratory syncytial virus prophylaxis to support the roll-out of a new liquid formation
- Value dossier update on respiratory syncytial virus
- Payer objection handlers to support treatment in secondary hyperparathyroidism (SHPT) and respiratory syncytial virus
- Economic evaluation of a treatment for respiratory syncytial virus
- Value communication support in acute otitis media associated with respiratory syncytial virus (RSV)
- Observational study and claims analysis of respiratory distress in infants with respiratory syncytial virus
- Development of an evidence package for a COA strategy for paediatric respiratory syncytial virus
- Content validation of a COA strategy for paediatric respiratory syncytial virus
- Exit interviews with caregivers and clinicians in a prospective study to assess the Paediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS)
- Content validation of a COA strategy for respiratory synctial virus in the elderly or in those with respiratory compromise